Analytical Profiles Of Drug Substances And Excipients

Hardcover | October 5, 1999

byHarry G. BrittainEditorBrittain

not yet rated|write a review
Although the official compendia define a drug substance as to identity, purity, strength, and quality, they normally do not provide other physical or chemical data, nor do they list methods of synthesis or pathways of physical or biological degradation and metabolism. Such information is scattered throughout the scientific literature and the files of pharmaceutical laboratories. Edited by the Associate Director of Analytical Research and Development for the American Association of Pharmaceutical Scientists, Analytical Profiles of Drug Substances and Excipients brings this information together into one source. The scope of the series has recently been expanded to include profiles of excipient materials.

Pricing and Purchase Info

$344.71 online
$403.82 list price (save 14%)
In stock online
Ships free on orders over $25

From the Publisher

Although the official compendia define a drug substance as to identity, purity, strength, and quality, they normally do not provide other physical or chemical data, nor do they list methods of synthesis or pathways of physical or biological degradation and metabolism. Such information is scattered throughout the scientific literature a...

Center for Pharmaceutical Physics, Milford, NJ, USA

other books by Harry G. Brittain

Polymorphism in Pharmaceutical Solids, Second Edition
Polymorphism in Pharmaceutical Solids, Second Edition

Kobo ebook|Apr 1 2016

$212.19 online$275.52list price(save 22%)
see all books by Harry G. Brittain
Format:HardcoverDimensions:508 pages, 9 × 6 × 0.98 inPublished:October 5, 1999Publisher:Academic PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0122608267

ISBN - 13:9780122608261

Look for similar items by category:

Customer Reviews of Analytical Profiles Of Drug Substances And Excipients

Reviews

Extra Content

Table of Contents

G. Indrayanto, A. Syahrani, Mugihardjo, A. Rahman, Soeharjono, W. Tanudjojo, S. Susanti, M. Yuwono, and S. Ebel,Benzoic Acid.R. Hall, G. Havner, J. Baker, G. Stafford, W. Schneider, W. Lin, J. May, M. Curtis, C. Struble, B. McCue, D. Jasheway, and D. McGee,Brinzolamide.A.H. Abadi, S. Rafatullah, and A.A. Al-Badr,Chlorpromazine.F.J. Muhtadi,Cortisone Acetate.A.A. Al-Majed, F. Belal, and A.A. Al-Badr,Diloxanide Furoate.M.-P. Quint, J. Grove, and S.M. Thomas,Dorsolamide Hydrochloride.B.D. Johnson, A. Howard, R. Varsolona, J. McCauley, and D.K. Ellison,Indinivar Sulfate.F. Belal, A.A. Al-Badr, and M.M. Tayel,Procaine Hydrochloride.A.W. Newman, I.M. Vitez, R.L. Mueller, C.C. Kiesnowski, W.P. Findlay, C. Rodriguez, M. Davidovich, and G. McGeorge.Cumulative Index.